Home Juno is just one part of Celgene's master plan
 

Keywords :   


Juno is just one part of Celgene's master plan

2015-07-17 23:53:28| Biotech - Topix.net

Seattle biotech Juno Therapeutics' new partner in the immunotherapy game isn't just interested in treatments for cancer. New Jersey biopharmaceutical company Celgene Corp. on Tuesday announced it will acquire San Diego-based autoimmune disease treatment company Receptos for $7.2 billion, about $232 per share .

Tags: part plan master juno

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Kim Madigan to chair 2025 FTA Fall Technical Conference
05.11PM responds to Sir Alan Bates after repeated requests
More »